FRESH-PEF165-en
Follow-up cohort of asthmatic patient treated with inhaled corticosteroid
OCSIGEN
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Pulmonary medicine | health theme |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants | health determinant |
{
"level_sex_clusion_I": [
{
"value": "Male",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
}
},
{
"value": "Female",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
}
}
],
"level_age_clusion_I": [
{
"value": "Young Adult (19 to 24 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D055815"
}
},
{
"value": "Adult (25 to 44 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000328"
}
},
{
"value": "Middle Aged (45 to 64 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
}
},
{
"value": "Aged (65 to 79 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
}
},
{
"value": "Aged, 80 and over (80 years and more)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000369"
}
}
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "GP section: The eligible population is defined by all of the asthmatic patients over the age of 15 years who have consulted at least twice in the previous year and in whom an inhaled corticotherapy is in progress (at least one prescription in the last six months). Patients defined as such who come to consult spontaneously for asthma during the period of inclusion will also be included. Pneumologist section:Asthmatic persons cared for in liberal pneumology present in the practice of the investigators of the study and meeting the inclusion criteria",
"clusion_E": "Refusal to participate and the association of the asthma with an OCPD are criteria for non-inclusion."
}
| Name |
|---|
| Céline;PRIBIL |
| Name | Role |
|---|---|
| GLAXOSMITHKLINE (FRANCE) | sponsor |
| Name |
|---|
| GLAXOSMITHKLINE (FRANCE) |
['Through independent healthcare practitioners']
['{"concept":{"vocabURI":"Probability.Stratified","vocab":"CESSDA"},"value":"Probability: Stratified"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2004-01-01 | 2009-01-01 |
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Céline;PRIBIL | celine.c.pribil@gsk.com |
FRESH-PEF165-en
| Name | Affiliation |
|---|---|
| Céline PRIBIL | GLAXOSMITHKLINE (FRANCE) |